via Penn Medicine
An experimental therapy has brought prolonged remissions to a high proportion of patients who were facing death from advanced leukemia after standard treatments had failed, researchers are reporting.
The therapy involves genetically programming cells from the patient’s own immune system to fight the disease.
The research included 30 patients: five adults ages 26 to 60, and 25 children and young adults ages 5 to 22. All were severely ill, with acute lymphoblastic leukemia, and had relapsed several times or had never responded to typical therapies. In more than half, the disease had come back even after a stem-cell transplant, which usually gives patients the best hope of surviving. Their life expectancy was a few months, or in some cases just weeks.
Six months after being treated, 23 of the 30 patients were still alive, and 19 of them have remained in complete remission.
The study, by researchers at the Children’s Hospital of Philadelphia and the Hospital of the University of Pennsylvania, is being published in The New England Journal of Medicine.
“We have a number of patients who are a year or more out and are in remission and not requiring other therapies,” said Dr. Stephan A. Grupp, who led the part of the study done at Children’s Hospital of Philadelphia. He said those long remissions gave the researchers hope that the treatment would have lasting effects.
Earlier reports by the same researchers involved only a handful of patients, some with chronic rather than acute leukemia. The scientists say the growing number of patients treated helps demonstrate that the findings are real.
The Latest on: Leukemia
via Google News
The Latest on: Leukemia
- Greater Huntsville Humane Society adding sanctuary for cats with leukemia and immunodeficiencyon February 28, 2021 at 5:34 am
The Rachel Ray Foundation partnered with another nonprofit, the Best Friends Society to grant these funds to the Humane Society, and put a dent in their efforts to create the first feline sanctuary ...
- Blessings in disguise: On year since my starting my journey with leukemiaon February 28, 2021 at 3:00 am
Republic’s Unleashed teen journalism program as an 11th grader in the fall of 2019. The following account details what happened in her life ...
- Community shows support for family of assistant basketball coach after son's leukemia diagnosison February 27, 2021 at 2:36 pm
The Harper family recently had to hear some of the worst news a parent could hear, and afterwards, people in their community sprang up to support them. Justin Harper, assistant basketball coach at ...
- When she was 13, she lost her friend to leukemia. Now, she’s honoring the girl’s legacy in the most touching way.on February 26, 2021 at 7:30 pm
In 2020, when the global COVID-19 pandemic had spread and people were hunkered down, we all likely thought about things we could do to keep busy or entertain ourselves. That was no different for ...
- Starr-Iva community rallies around 11 year-old battling two types of Leukemiaon February 26, 2021 at 3:26 pm
The Starr-Iva community is standing beside an 11 year-old boy, who is fighting Leukemia. Schools like Crescent High School, Starr-Iva Middle, and Flat Rock Elementary, have ...
- Invading retrovirus linked to high rates of lymphoma, leukemia among koalason February 26, 2021 at 10:42 am
New research suggests koala retrovirus, or KoRV, is responsible for elevated rates of lymphoma, leukemia and other cancers among northern Australia's koala population.
- 'Sawyer Strong': Iowa communities come together to help boy fighting leukemiaon February 26, 2021 at 5:11 am
Less than a month after being diagnosed with leukemia, a 5-year-old Iowa boy and his family are receiving love and support from people in communities across the state. Sawyer England was diagnosed ...
- Overcoming chemotherapy resistance in leukemia with a diarrhea drug from Merckon February 25, 2021 at 5:40 am
Although acute myeloid leukemia (AML) is treatable with chemotherapy, patients often become resistant to it. Researchers at King’s College in London discovered that Merck’s drug Dificid, which ...
- Acute myeloid leukemia: current progress and future directionson February 22, 2021 at 10:19 am
Progress in understanding the pathophysiology and improving the therapy of acute myeloid leukemia (AML) is now occurring at a rapid pace. The discovery of the activity of cytarabine (ara-C) and of ...
- Knocking Out Chronic Myeloid Leukemia with Precisionon February 22, 2021 at 6:06 am
Patients with chronic myeloid leukemia are living longer, some even stopping treatment, thanks to a plethora of targeted therapies.
via Bing News
